
ELTX
USDElicio Therapeutics Inc. Common Stock
$9.150-0.120 (-1.294%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$9.270
High
$9.550
Low
$9.070
Volume
0.01M
Company Fundamentals
Market Cap
149.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.11M
Exchange
NCM
Currency
USD
52-Week Range
Low $4.6Current $9.150High $12.62
Related News
GlobeNewswire
Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma
Study will evaluate ELI-002 7P in combination with chemotherapy and a checkpoint inhibitor ("CPI") in the neoadjuvant settingTrial is anticipated to begin enrolling in H1'2026
View more
Related Stocks
MSSA
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ
Blank Checks
BSX
Boston Scientific Corporation
NASDAQ
Medical/Dental ...
ARCT
Arcturus Therapeutics Holdings Inc.
NASDAQ
Biotechnology: ...
XFLT
XAI Octagon Floating Rate & Alternative Income Trust Common Shares of Beneficial Interest
NASDAQ
Investment Mana...
RZLT
Rezolute Inc. (NV)
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.